Literature DB >> 23568679

Swab cultures are not as effective as tissue cultures for diagnosis of periprosthetic joint infection.

Vinay K Aggarwal1, Carlos Higuera, Gregory Deirmengian, Javad Parvizi, Matthew S Austin.   

Abstract

BACKGROUND: While it is accepted accurate identification of infecting organisms is crucial in guiding treatment of periprosthetic joint infection (PJI), there remains no consensus regarding the best method for obtaining cultures. QUESTIONS/PURPOSES: We compared the yield of intraoperative tissue samples versus swab cultures in diagnosing PJI.
METHODS: Tissue and swab cultures (three each) were collected prospectively during a consecutive series of 156 aseptic and septic revision arthroplasties from October 2011 to April 2012. The tissues and swabs were taken from standardized regions of the joint. After excluding 39 reimplantation procedures, we included 117 cases (74 hip, 43 knee; 30 septic, 87 aseptic) for analysis. We used a modified version of the Musculoskeletal Infection Society criteria for defining PJI, requiring three of five rather than four of six criteria. Tissue and swab cultures from septic and aseptic cases were used to calculate their sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) for identifying PJI.
RESULTS: Tissue cultures were positive in a higher percentage of septic cases than swab cultures: 28 of 30 (93%) versus 21 of 30 (70%). Tissue cultures were positive in two of 87 aseptic cases (2%), while swab cultures were positive in 10 of 87 (12%). The sensitivity, specificity, PPV, and NPV were 93%, 98%, 93%, and 98%, respectively, for tissue cultures and 70%, 89%, 68%, and 90%, respectively, for swab cultures.
CONCLUSIONS: Tissue cultures demonstrated higher sensitivity, specificity, PPV, and NPV for diagnosing PJI than swab cultures. Swab cultures had more false-negative and false-positive results than tissue cultures. Because swab cultures pose a higher risk of not identifying or incorrectly identifying infecting organisms in PJI, we believe their use in obtaining intraoperative culture specimens should be discouraged. LEVEL OF EVIDENCE: Level II, diagnostic study. See Guidelines for Authors for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2013        PMID: 23568679      PMCID: PMC3773152          DOI: 10.1007/s11999-013-2974-y

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  27 in total

1.  Histological and microbiological findings in non-infected and infected revision arthroplasty tissues. The OSIRIS Collaborative Study Group. Oxford Skeletal Infection Research and Intervention Service.

Authors:  R Pandey; A R Berendt; N A Athanasou
Journal:  Arch Orthop Trauma Surg       Date:  2000       Impact factor: 3.067

2.  The Mark Coventry Award: diagnosis of early postoperative TKA infection using synovial fluid analysis.

Authors:  Hany Bedair; Nicholas Ting; Christina Jacovides; Arjun Saxena; Mario Moric; Javad Parvizi; Craig J Della Valle
Journal:  Clin Orthop Relat Res       Date:  2011-01       Impact factor: 4.176

Review 3.  Biofilm theory can guide the treatment of device-related orthopaedic infections.

Authors:  J William Costerton
Journal:  Clin Orthop Relat Res       Date:  2005-08       Impact factor: 4.176

4.  Periprosthetic infection: what are the diagnostic challenges?

Authors:  Javad Parvizi; Elie Ghanem; Sarah Menashe; Robert L Barrack; Thomas W Bauer
Journal:  J Bone Joint Surg Am       Date:  2006-12       Impact factor: 5.284

5.  Prosthetic joint infection diagnosis using broad-range PCR of biofilms dislodged from knee and hip arthroplasty surfaces using sonication.

Authors:  Eric Gomez; Charles Cazanave; Scott A Cunningham; Kerryl E Greenwood-Quaintance; James M Steckelberg; James R Uhl; Arlen D Hanssen; Melissa J Karau; Suzannah M Schmidt; Douglas R Osmon; Elie F Berbari; Jayawant Mandrekar; Robin Patel
Journal:  J Clin Microbiol       Date:  2012-08-15       Impact factor: 5.948

6.  Prospective analysis of preoperative and intraoperative investigations for the diagnosis of infection at the sites of two hundred and two revision total hip arthroplasties.

Authors:  M J Spangehl; B A Masri; J X O'Connell; C P Duncan
Journal:  J Bone Joint Surg Am       Date:  1999-05       Impact factor: 5.284

Review 7.  Is aseptic loosening truly aseptic?

Authors:  Carl L Nelson; Alex C McLaren; Sandra G McLaren; Jeffrey W Johnson; Mark S Smeltzer
Journal:  Clin Orthop Relat Res       Date:  2005-08       Impact factor: 4.176

8.  Improved diagnosis of periprosthetic joint infection by multiplex PCR of sonication fluid from removed implants.

Authors:  Yvonne Achermann; Markus Vogt; Michael Leunig; Jürg Wüst; Andrej Trampuz
Journal:  J Clin Microbiol       Date:  2010-02-17       Impact factor: 5.948

9.  Perioperative testing for joint infection in patients undergoing revision total hip arthroplasty.

Authors:  Mark F Schinsky; Craig J Della Valle; Scott M Sporer; Wayne G Paprosky
Journal:  J Bone Joint Surg Am       Date:  2008-09       Impact factor: 5.284

10.  Prolonged bacterial culture to identify late periprosthetic joint infection: a promising strategy.

Authors:  Peter Schäfer; Bernd Fink; Dieter Sandow; Andreas Margull; Irina Berger; Lars Frommelt
Journal:  Clin Infect Dis       Date:  2008-12-01       Impact factor: 9.079

View more
  43 in total

1.  The use of spacers (static and mobile) in infection knee arthroplasty.

Authors:  Luca Mazzucchelli; Federica Rosso; Antongiulio Marmotti; Davide Edoardo Bonasia; Matteo Bruzzone; Roberto Rossi
Journal:  Curr Rev Musculoskelet Med       Date:  2015-12

Review 2.  [Implant-associated infections - Diagnostics].

Authors:  N Renz; M Müller; C Perka; A Trampuz
Journal:  Chirurg       Date:  2016-10       Impact factor: 0.955

3.  Preoperative aspiration culture for preoperative diagnosis of infection in total hip or knee arthroplasty.

Authors:  Xinhua Qu; Zanjing Zhai; Chuanlong Wu; Fangchun Jin; Haowei Li; Lei Wang; Guangwang Liu; Xuqiang Liu; Wengang Wang; Huiwu Li; Xiaoyu Zhang; Zhenan Zhu; Kerong Dai
Journal:  J Clin Microbiol       Date:  2013-08-14       Impact factor: 5.948

4.  Optimal culture incubation time in orthopedic device-associated infections: a retrospective analysis of prolonged 14-day incubation.

Authors:  Nora Schwotzer; Peter Wahl; Dominique Fracheboud; Emanuel Gautier; Christian Chuard
Journal:  J Clin Microbiol       Date:  2013-10-23       Impact factor: 5.948

Review 5.  [Osteosynthesis-associated infections : Epidemiology, definition and diagnosis].

Authors:  N Renz; S Feihl; C E Dlaska; M A Schütz; A Trampuz
Journal:  Unfallchirurg       Date:  2017-06       Impact factor: 1.000

6.  Infection post-total knee replacement: current concepts.

Authors:  Pouya Alijanipour; Javad Parvizi
Journal:  Curr Rev Musculoskelet Med       Date:  2014-06

7.  Serum interleukin 6 could be a valuable initial diagnostic tool in prosthetic knee joint infections.

Authors:  Isaac Majors; Vivek S Jagadale
Journal:  Eur J Orthop Surg Traumatol       Date:  2019-07-26

8.  Development of a Novel and Rapid Antibody-Based Diagnostic for Chronic Staphylococcus aureus Infections Based on Biofilm Antigens.

Authors:  Janette M Harro; Mark E Shirtliff; William Arnold; Jennifer M Kofonow; Chad Dammling; Yvonne Achermann; Kristen Brao; Javad Parvizi; Jeff G Leid
Journal:  J Clin Microbiol       Date:  2020-04-23       Impact factor: 5.948

9.  Method of intraoperative tissue sampling for culture has an effect on contamination risk.

Authors:  Antonia F Chen; Meredith Menz; Priscilla K Cavanaugh; Javad Parvizi
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-09-12       Impact factor: 4.342

10.  Prospective Analysis of a Sterile, Semi-automated Tissue Biopsy Homogenization Method in the Diagnosis of Prosthetic Joint Infections.

Authors:  Christian Suren; Norbert Harrasser; Florian Pohlig; Ingo J Banke; Ulrich Lenze; Florian Lenze; Carolin Knebel; Rüdiger VON Eisenhart-Rothe; Johannes Schauwecker; Heinrich M L Mühlhofer
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.